Precigen (PGEN) Selling, General & Administrative (2012 - 2026)
Precigen (PGEN) Selling, General & Administrative (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
2.17 Mn |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-1.52 Mn |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
-7.36 Mn |
| 10 |
Precigen |
1.32 Bn |
1.32 Bn |
20.69 Mn |
21.05 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
21.05 Mn |
| Dec 31, 2025 |
17.65 Mn |
| Sep 30, 2025 |
23.99 Mn |
| Jun 30, 2025 |
16.13 Mn |
| Mar 31, 2025 |
12.36 Mn |
| Dec 31, 2024 |
11.00 Mn |
| Sep 30, 2024 |
9.84 Mn |
| Jun 30, 2024 |
10.31 Mn |
| Mar 31, 2024 |
10.15 Mn |
| Dec 31, 2023 |
10.27 Mn |
| Sep 30, 2023 |
9.20 Mn |
| Jun 30, 2023 |
9.32 Mn |
| Mar 31, 2023 |
11.64 Mn |
| Dec 31, 2022 |
11.51 Mn |
| Sep 30, 2022 |
10.14 Mn |
| Jun 30, 2022 |
12.67 Mn |
| Mar 31, 2022 |
13.69 Mn |
| Dec 31, 2021 |
11.80 Mn |
| Sep 30, 2021 |
10.98 Mn |
| Jun 30, 2021 |
14.95 Mn |
